These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24620801)

  • 21. Comparison of assay formats for drug-tolerant immunogenicity testing.
    Butterfield AM; Chain JS; Ackermann BL; Konrad RJ
    Bioanalysis; 2010 Dec; 2(12):1961-9. PubMed ID: 21110740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics.
    Lee JW
    Bioanalysis; 2009 Nov; 1(8):1461-74. PubMed ID: 21083095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.
    Ezan E; Becher F; Benech H; Fenaille F; Junot C; Mabondzo A; Pruvost A
    Bioanalysis; 2010 Apr; 2(4):713-7. PubMed ID: 21083268
    [No Abstract]   [Full Text] [Related]  

  • 24. Feedback from the European Bioanalysis Forum Workshop: taking tiered approach to the next level.
    Timmerman P; White S; Knutsson M; Kall MA; Fjording MS; Smeraglia J; McDougall S
    Bioanalysis; 2014; 6(19):2593-8. PubMed ID: 25411702
    [No Abstract]   [Full Text] [Related]  

  • 25. [Defense and illustration of biological levels].
    Damas J
    Rev Med Liege; 1981 Oct; 36(20):741-5. PubMed ID: 7323533
    [No Abstract]   [Full Text] [Related]  

  • 26. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Special section: 23rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2011), 9-12 october 2011, João Pessoa, PB, Brazil.Preface.
    Cass QB
    J Pharm Biomed Anal; 2013 Jan; 73():1-2. PubMed ID: 22785375
    [No Abstract]   [Full Text] [Related]  

  • 28. Virus assay methods: accuracy and validation.
    Darling AJ; Boose JA; Spaltro J
    Biologicals; 1998 Jun; 26(2):105-10. PubMed ID: 9811514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence-based liver microsomal assay for screening of pharmaceutical reactive metabolites using a glutathione conjugated 96-well plate.
    Ma X; Chan EC
    Bioconjug Chem; 2010 Jan; 21(1):46-55. PubMed ID: 19957910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations on biomarker bioanalytical method validation by GCC.
    Hougton R; Gouty D; Allinson J; Green R; Losauro M; Lowes S; LeLacheur R; Garofolo F; Couerbe P; Bronner S; Struwe P; Schiebl C; Sangster T; Pattison C; Islam R; Garofolo W; Pawula M; Buonarati M; Hayes R; Cameron M; Nicholson R; Harman J; Wieling J; De Boer T; Reuschel S; Cojocaru L; Harter T; Malone M; Nowatzke W
    Bioanalysis; 2012 Oct; 4(20):2439-46. PubMed ID: 23157353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment.
    Bautista AC; Wullner D; Moxness M; Swanson SJ; Chirmule N; Jawa V
    Bioanalysis; 2010 Apr; 2(4):721-31. PubMed ID: 21083270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State of the art analytical comparability: a review.
    Chirino AJ; Mire-Sluis AR
    Dev Biol (Basel); 2005; 122():3-26. PubMed ID: 16375248
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioanalysis of biomarkers for drug development.
    Fidock M; DeSilva B
    Bioanalysis; 2012 Oct; 4(20):2425-6. PubMed ID: 23157349
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay.
    Zhu Z; Puglisi J; Connors D; Stewart J; Herbst J; Marino A; Sinz M; O'Connell J; Banks M; Dickinson K; Cacace A
    J Biomol Screen; 2007 Mar; 12(2):248-54. PubMed ID: 17259590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supramolecular devices for the high-throughput screening of drugs, nutrients and metabolites in postgenomic era (part 1).
    Bazylak G
    Comb Chem High Throughput Screen; 2007 Jun; 10(5):299-300. PubMed ID: 17896925
    [No Abstract]   [Full Text] [Related]  

  • 36. A generic operational strategy to qualify translational safety biomarkers.
    Matheis K; Laurie D; Andriamandroso C; Arber N; Badimon L; Benain X; Bendjama K; Clavier I; Colman P; Firat H; Goepfert J; Hall S; Joos T; Kraus S; Kretschmer A; Merz M; Padro T; Planatscher H; Rossi A; Schneiderhan-Marra N; Schuppe-Koistinen I; Thomann P; Vidal JM; Molac B
    Drug Discov Today; 2011 Jul; 16(13-14):600-8. PubMed ID: 21570476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring soluble biomarkers in clinical trials: do tiered approaches to the analysis and validation of assays provide an answer to the fit-for-purpose challenge?
    Hucker R; Watson C; James I; Vincent S; Muirhead D
    Bioanalysis; 2014 Mar; 6(5):605-9. PubMed ID: 24620802
    [No Abstract]   [Full Text] [Related]  

  • 39. A narrative for bioanalytical method development.
    Tremblay G
    Bioanalysis; 2017 Feb; 9(3):233-234. PubMed ID: 28084801
    [No Abstract]   [Full Text] [Related]  

  • 40. The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis.
    Savoie N; Booth BP; Bradley T; Garofolo F; Hughes NC; Hussain S; King SP; Lindsay M; Lowes S; Ormsby E; Phull R; Rocci ML; Vallano PT; Viau A; Zhu Z
    Bioanalysis; 2009 Apr; 1(1):19-30. PubMed ID: 21083184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.